Previous 10 |
home / stock / mvrbf / mvrbf news
Medivir AB ( OTC:MVRBF ): Q1 GAAP EPS of -SEK2.30. More news on: Medivir AB (publ), Medivir AB ADR, Earnings news and commentary, Tech stocks news, , Read more ...
HUDDINGE, Sweden , May 3, 2019 /PRNewswire/ --January – March Significant events during the quarter The phase II study of birinapant in combination with Keytruda® in colorectal cancer patients progresses according to plan. A futility analysis is planned to be cond...
HUDDINGE, Sweden , April 29, 2019 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces the appointment of Magnus Christensen as new CFO of Medivir effective as of 12 August 2019 . He will also join the company's management team. In his role, Magnus will be respo...
HUDDINGE, Sweden , Feb. 18, 2019 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) as previously announced, Erik Björk will leave the role as Medivir's CFO. Lotta Ferm will assume the role as interim CFO as of March 1st . Recruitment of a permanent CFO is ongoing. For furth...
Medivir ABB ( OTC:MVRBF ): Q4 GAAP EPS of -SEK4.72. More news on: Medivir ABB, Earnings news and commentary, Tech stocks news, , Read more ...
HUDDINGE, Sweden , Feb. 14, 2019 /PRNewswire/ -- Two new projects into clinic October – December Significant events during the quarter The first patient was dosed in the phase II study with birinapant and Keytruda® as combination therapy in colorectal cancer. ...
News, Short Squeeze, Breakout and More Instantly...
Medivir B Company Name:
MVRBF Stock Symbol:
OTCMKTS Market:
MEDIVIR AB - INTERIM REPORT JANUARY - JUNE 2022 PR Newswire STOCKHOLM , Aug. 19, 2022 /PRNewswire/ -- The clinical development of fostrox remains the focus April - June Financial summary for the quarter Net turnover amoun...
Birinapant clinical study initiated by IGM Biosciences PR Newswire STOCKHOLM , Nov. 4, 2021 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR ) today announced that IGM Biosciences, Inc. has initiated its clinical study in solid cancers with birinapant (...
Medivir to present at the ProHearings shared Capital Markets Day PR Newswire STOCKHOLM , Oct. 11, 2021 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the ProHearings shared Capital Markets Day, Octo...